Hiral Anil Shah

Employment

• GSK Vaccines Modelling Director
  2025 - Present
• GSK plc Associate Director, Neisseria Portfolio
  2022 - 2025
• Center for Global Development Senior Policy Analyst (Global Health Economics)
  2020 - 2022
• Imperial College London Visiting Researcher
  2020 - 2021

Education

• Imperial College London PhD Epidemiology, Economics & Ecology
  2016 - 2020
• London School of Hygiene and Tropical Medicine MSc Public Health (Health Economics)
  2013 - 2014
• Aston University BSc (Hons) Applied Chemistry with Industrial Experience
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (20)

• Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States
  PharmacoEconomics 2026 DOI: 10.1007/s40273-026-01599-z
  +Save
• Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA
  PharmacoEconomics 2025 DOI: 10.1007/s40273-025-01477-0
  +Save
• Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States
  PharmacoEconomics 2025 DOI: 10.1007/s40273-024-01439-y
  +Save
• Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India
  BMJ Evidence-Based Medicine 2025 DOI: 10.1136/bmjebm-2023-112490
  +Save
• Inequalities in the risk and prevention of invasive meningococcal disease in the United States – A systematic literature review
  Human Vaccines & Immunotherapeutics 2024 DOI: 10.1080/21645515.2024.2406613
  +Save
• Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment
  Infectious Diseases and Therapy 2024 DOI: 10.1007/s40121-024-01017-x
  +Save
• Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis
  Infectious Diseases and Therapy 2024 DOI: 10.1007/s40121-023-00899-7
  +Save
• Healthcare resource use and costs of varicella and its complications: A systematic literature review
  Human Vaccines & Immunotherapeutics 2023 DOI: 10.1080/21645515.2023.2266225
  +Save
• Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania
  PharmacoEconomics - Open 2023 DOI: 10.1007/s41669-023-00418-x
  +Save
• Resource use, availability and cost in the provision of critical care in Tanzania: a systematic review
  BMJ Open 2022 DOI: 10.1136/bmjopen-2021-060422
  +Save